Healthy Skepticism Library item: 10198

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Baumevieille M, Begaud B, Maurain C.
[Charter of medicines promotion and rational use by physicians].
Therapie 2007 Jan-Feb; 62:(1):39-44
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17374346&query_hl=16&itool=pubmed_DocSum

Abstract:

The charter of medicines promotion recently adopted by France intends to constrain information given by sales representatives to the field of good prescription practices. Over a 11 year period (1994 to end 2004), 362 interdictions of promotional supports have been decided by the director of the French Medicines Agency. This accounts for 0.5% of the about 80 800 promotional supports controlled during this period. A date base shows the representation of the justifications of these interdictions and the predominance of documentation given or showed to the physicians. A challenge for health authorities would be to assess the actual impact of ethical and non ethical promotion.

Keywords:
Publication Types: English Abstract MeSH Terms: Drug Industry/ethics Drug Industry/legislation & jurisprudence* France Legislation, Drug/trends* Marketing/ethics Marketing/standards Prescriptions, Drug/standards

Notes:

French.